Google
RVLPQ — RVL PHARMACEUTICALS PLC (Healthcare >> Biotechnology)
RVLPQ FAQ
What is RVLPQ's ROE?
RVL PHARMACEUTICALS PLC reports a Return on Equity (ROE) of -418.14%.
What is RVLPQ's dividend yield?
RVL PHARMACEUTICALS PLC offers a dividend yield of 0.00%.
What is RVLPQ's Deepscope Quality Score?
Deepscope rates RVLPQ's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.
Which sector does RVLPQ belong to?
RVL PHARMACEUTICALS PLC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD N/A
Price
0
(0%)
Day Change
|
|
|---|
Not enough data to analyze.
Loading chart...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROE is relatively low.
ROA is relatively low.
Historical ROE is relatively low
Negative growth of ROE in the last year.
ROE is decreasing significantly
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not good , financial health is not good , and ability to make profit is ok , ...
| Quality Factors |
|
45% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 99 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | N/A |
| PBV / Sector |
N/A / 4.75
|
| Earning Per Share | N/A |
| PE / Sector |
N/A / 17.65
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
0.000000000000
|
| Average 1W Daily Value |
0.000000000000
|
| Timing Factors |
|
57% |
| Financial Health |
|
37% |
| Ability to Make Profit |
|
64% |
| Return to Investors |
|
8% |
| Registration Details |
| Analyze Date | 2026-06-09 09:39:56 |
| Symbol | RVLPQ |
| Name | RVL PHARMACEUTICALS PLC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 111.41 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | N/A / 9,000.42 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 400 Crossing Boulevard, Bridgewater, NJ, United States, 08807
Phone: 908 809 1300
Website: https://www.rvlpharma.com
Employees: 125
Sector: Healthcare >> Biotechnology
Description: RVL Pharmaceuticals plc operates as a specialty pharmaceutical company in the United States, Argentina, and Hungary. It focuses on the development and commercialization of pharmaceutical products that target markets with underserved patient populations in the ocular and medical aesthetics therapeutic areas. It is commercializing Upneeq (RVL-1201), an oxymetazoline hydrochloride ophthalmic solution, for the treatment of acquired blepharoptosis, or low-lying eyelid in adults. The company was formerly known as Osmotica Pharmaceuticals plc and changed its name to RVL Pharmaceuticals plc in January 2022. RVL Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
